Kaempferol: antimicrobial properties, sources, clinical, and traditional applications
A Periferakis, K Periferakis, IA Badarau… - International journal of …, 2022 - mdpi.com
Flavonoids are a category of plant-derived compounds which exhibit a large number of
health-related effects. One of the most well-known and studied flavonoids is kaempferol …
health-related effects. One of the most well-known and studied flavonoids is kaempferol …
Human african trypanosomiasis
P Büscher, G Cecchi, V Jamonneau, G Priotto - The Lancet, 2017 - thelancet.com
Human African trypanosomiasis (sleeping sickness) is a parasitic infection that almost
invariably progresses to death unless treated. Human African trypanosomiasis caused …
invariably progresses to death unless treated. Human African trypanosomiasis caused …
[图书][B] Lutte antivectorielle et élimination de la trypanosomiase humaine africaine (THA) à gambiense: réunion conjointe d'experts FAO/OMS (Réunion en ligne) 5–6 …
World Health Organization - 2022 - books.google.com
Page 1 PROGRAMME DE LUTTE CO CONTRE lutte contre LA de Programme SOMOSE
AFRICAINE PLTA FAO-AIEA - OMS - UA PROMOUVOIR L'AGRICULTURE ET LA SANTÉ la …
AFRICAINE PLTA FAO-AIEA - OMS - UA PROMOUVOIR L'AGRICULTURE ET LA SANTÉ la …
The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020
Background In the 20th century, epidemics of human African trypanosomiasis (HAT)
ravaged communities in a number of African countries. The latest surge in disease …
ravaged communities in a number of African countries. The latest surge in disease …
Epidemiology of human African trypanosomiasis
JR Franco, PP Simarro, A Diarra… - Clinical epidemiology, 2014 - Taylor & Francis
Human African trypanosomiasis (HAT), or sleeping sickness, is caused by Trypanosoma
brucei gambiense, which is a chronic form of the disease present in western and central …
brucei gambiense, which is a chronic form of the disease present in western and central …
Monitoring the elimination of human African trypanosomiasis: Update to 2014
Background The World Health Organization (WHO) has targeted the elimination of Human
African trypanosomiasis (HAT)'as a public health problem'by 2020. The selected indicators …
African trypanosomiasis (HAT)'as a public health problem'by 2020. The selected indicators …
Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018
Background In 2012 human African trypanosomiasis (HAT), also known as sleeping
sickness, was targeted for elimination as a public health problem, set to be achieved by …
sickness, was targeted for elimination as a public health problem, set to be achieved by …
Estimating and mapping the population at risk of sleeping sickness
PP Simarro, G Cecchi, JR Franco… - PLoS neglected …, 2012 - journals.plos.org
Background Human African trypanosomiasis (HAT), also known as sleeping sickness,
persists as a public health problem in several sub-Saharan countries. Evidence-based …
persists as a public health problem in several sub-Saharan countries. Evidence-based …
The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000–2009: the way forward
PP Simarro, A Diarra, JA Ruiz Postigo… - PLoS neglected …, 2011 - journals.plos.org
Background One century ago human African trypanosomiasis (HAT), also known as
sleeping sickness, was believed to curb the development of colonial territories. As soon as …
sleeping sickness, was believed to curb the development of colonial territories. As soon as …
A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis
P Babokhov, AO Sanyaolu, WA Oyibo… - Pathogens and global …, 2013 - Taylor & Francis
Despite the recent advances in drug research, finding a safe, effective, and easy to use
chemotherapy for human African trypanosomiasis (HAT) remains a challenging task. The …
chemotherapy for human African trypanosomiasis (HAT) remains a challenging task. The …